Profilo
James Streisand worked at Genzyme Corp.
from 1998 to 2011, including the role of Vice President-Clinical Research in 2011.
Dr. Streisand worked at Sanofi from 2011 to 2013 as Vice President-Clinical Development in 2013.
Dr. Streisand worked at rEVO Biologics, Inc. as Vice President-Clinical Development.
Dr. Streisand completed undergraduate education at Massachusetts Institute of Technology and earned a doctorate from State University of New York at Buffalo.
Precedenti posizioni note di James Streisand
| Società | Posizione | Fine |
|---|---|---|
| SANOFI | Corporate Officer/Principal | 01/06/2013 |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 01/04/2011 |
| REVO BIOLOGICS INC | Direttore Tecnico/Scientifico/R&S | - |
Formazione di James Streisand
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
State University of New York at Buffalo
State University of New York at Buffalo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
rEVO Biologics, Inc.
rEVO Biologics, Inc. BiotechnologyHealth Technology Develops and commercializes specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions | Health Technology |
















